Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay

Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma

(2019) Heidi Britton et al.   GYNECOLOGIC ONCOLOGY

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

(2018) Tjalling Bosse et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Molecular insights into the classification of high-grade endometrial carcinoma

(2018) Yaser R. Hussein et al.   PATHOLOGY

Molecular Genetics of Endometrial Carcinoma

(2018) Daphne W. Bell et al.   Annual Review of Pathology-Mechanisms of Disease

Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement

(2017) Naoki Nakajima et al.   HISTOPATHOLOGY

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer

(2017) Hui Yu et al.   Journal of Thoracic Oncology

A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution

(2017) Larissa Erben et al.   MOLECULAR NEUROBIOLOGY

Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution

(2017) Ann-Marie Baker et al.   Nature Communications

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis

(2016) M. K. McConechy et al.   CLINICAL CANCER RESEARCH

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

(2016) Ellen Stelloo et al.   CLINICAL CANCER RESEARCH

Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas

(2016) Adele Wong et al.   GYNECOLOGIC ONCOLOGY

Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence

(2016) Caroline C. Billingsley et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

(2016) D. Scott McMeekin et al.   JOURNAL OF CLINICAL ONCOLOGY

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

(2015) Johnathan M. Lancaster et al.   GYNECOLOGIC ONCOLOGY

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria

(2015) Tae Wook Kong et al.   Journal of Gynecologic Oncology

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

(2015) Ellen Stelloo et al.   MODERN PATHOLOGY

Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication

(2014) Eve Shinbrot et al.   GENOME RESEARCH

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium

(2014) Bo Meng et al.   GYNECOLOGIC ONCOLOGY

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

(2014) David N. Church et al.   JNCI-Journal of the National Cancer Institute

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) N. Colombo et al.   ANNALS OF ONCOLOGY

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

High-grade endometrial carcinomas - strategies for typing

(2012) Robert A Soslow   HISTOPATHOLOGY

High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and Outcomes

(2010) Abdulmohsen Alkushi et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Are Uterine Risk Factors More Important Than Nodal Status in Predicting Survival in Endometrial Cancer?

(2009) Janice S. Kwon et al.   OBSTETRICS AND GYNECOLOGY